Mike Havrilla (another blogger) is now following a 2nd small cap medical/pharma stock that I am an investor. ROCM was the first stock he has also been bullish on and Aspen BioPharma (APPY) is the second.I first noticed Mike on the ROCM Investor Village Message Board where he shared out his notes and analyst report on ROCM (suggesting a 2008 price target of more than $25 a share).
Today, I noticed a blog listed on Seeking Alpha about Aspen's new innovative blood screening test for appendicitis called AppyScore (the reason I am an investor). I really can't say it any better than he can. He gives a great re-cap on the APPY story: AspenBio Pharma: Poised to Ascend New Heights
No comments:
Post a Comment